Aurobindo Pharma shares traded higher on Tuesday despite a slight dip in its FY25 fourth-quarter profits to ₹903 crore. On technical cues, analyst Manish Kushwaha advised caution, adding that the stock needs to clear ₹1,250 for a fresh rally or it may slide to ₹1,050.